Show all images
Shilpa Medicare Ltd - CDMO/CMO
Started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets.
Shilpa Medicare is a fully integrated pharmaceutical company, present across the entire value chain from Research and Development, Active Pharmaceutical Ingredients, Finished Formulations, Biologicals, ODF, Derma, Peptides & Polymers etc.
Currently we are one of the leaders in the Oncology market and offer a complete range of products in this segment spanning across APIs, formulations both in terms of R&D and manufacturing capabilities. Further to consolidation in field of oncology API and formulations, we are striving to put in our efforts in field of novel...
India
Local time:
6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO
R&D Centers with capabilities of ANDAs, DMFs and NDDS
462+ patents filed for drug substances and polymorphs
Production scale:
Response time:
Services
Drug Substance (CDMO/CRO)
Drug Product (CMO)
Replies quickly
Replies quickly
Replies quickly
Contact Shilpa Medicare Ltd for Contract Services Expertise
Connect with Shilpa Medicare Ltd, a leading pharmaceutical company from India. They offer specialized Drug Substance (CDMO/CRO), Drug Product (CMO), of which the services for CMO/CDMO include Tablets & Capsules, Liquid Vials, Prefilled Syringes. Contact Shilpa Medicare Ltd for free and discover if they are the perfect partner for your pharmaceutical needs.
Drug Substance (CDMO/CRO)
Drug Substance (often called the API, active pharmaceutical ingredient) is the active ingredient that becomes the core of a medicine
before it is formulated into tablets, capsules, injectables, or other dosage forms.
Outsourcing this stage typically involves a pharmaceutical CDMO that provides CDMO services such as process development,
scale-up, tech transfer, and CDMO manufacturing under GMP.
We use CDMO/CRO here because many partners combine development and manufacturing, and some also offer CRO-style support
(specialized analytical development, early-stage research services, feasibility work). Buyers searching for CDMO outsourcing usually want one thing:
a partner that can reliably deliver the right API at the right quality level for the target markets (FDA, EMA, PMDA and others).
These quick notes help you evaluate CDMO outsourcing partners for drug substance manufacturing without reading a full outsourcing handbook.
In drug substance work, a CDMO typically owns the “development + manufacturing” path, while CRO services are used to accelerate specific research or analytical tasks.
In practice, many contract development manufacturing organization partners offer both.
Common questions buyers ask when comparing CDMO companies for drug substance (API) manufacturing.
Drug substance manufacturing is the development and production of the active ingredient (API) used in a medicine.
It often includes process development, scale-up, GMP manufacturing, analytical methods, and documentation for target markets.
A pharmaceutical CDMO is a contract partner that provides development and manufacturing services, often end-to-end:
process development, scale-up, tech transfer, validation, and GMP production (CDMO manufacturing).
Many drug substance partners offer both CDMO execution and CRO-style support, such as specialized analytical development,
feasibility work, and early-stage research services. The right choice depends on scope, not the label.
Involve CRO support when you need specialized analytical development, rapid feasibility work, or research-heavy services that complement the CDMO scope.
Many buyers use CDMO services for development + manufacturing and add CRO services for specific tasks.
Start with scope (development vs manufacturing), then match capability (chemistry/biology, potency, scale),
validate GMP credentials and supported markets (FDA/EMA/PMDA), and finally check capacity and lead times.
Include API type, stage, batch sizes and annual demand estimate, target markets, known impurities/critical quality attributes,
required containment/OEB, timeline, and which services you expect (process development, tech transfer, GMP manufacturing, QC).
If potency or OEB limits require closed handling and validated containment, shortlist partners with dedicated suites,
documented exposure controls, and experience with similar compounds at comparable scales.
Very. In-house analytical development and QC often reduce transfer friction and shorten timelines.
Ask what is truly in-house (methods, stability, impurity profiling) versus outsourced.
Look for relevant inspections/certifications aligned to your target markets (FDA, EMA, etc.), and confirm that the specific facility and suites are in-scope.
Mature quality systems (deviations/CAPA, change control) matter as much as certificates.
Process complexity, containment requirements, analytical method readiness, documentation needs for target markets, and capacity constraints.
Clear scope and good transfer documentation reduce delays.
Sometimes, but often facilities and expertise differ. Validate modality fit (biologics vs chemical-synthetic),
equipment and containment, and comparable project references.
Compare on scope (what’s included), proven experience at similar scales, GMP maturity, analytical capabilities, supported markets, lead times,
and how change control and deviations are handled. Use filters above to remove obvious mismatches first.
What is Drug Substance outsourcing (CDMO/CRO)?
Drug Substance buyer guide (CDMO/CRO)
When do you need a CDMO vs CRO (or both)?
What to ask a Drug Substance CDMO
Key terms (Drug Substance)
Drug Substance CDMO services FAQ
What does “Drug Substance manufacturing” mean?
What is a pharmaceutical CDMO?
Why do you label this as CDMO/CRO?
When should I involve a CRO in drug substance work?
How do I shortlist CDMO companies quickly for API manufacturing?
What should I include in an RFQ to a Drug Substance CDMO?
Do I need a dedicated HPAPI facility?
How important is in-house analytical capability?
What GMP evidence should I look for?
What affects CDMO outsourcing timelines the most?
Can a biotech CDMO also support small molecule APIs?
How do I compare CDMO services fairly across providers?
Drug Product (CMO)
What is Drug Product outsourcing (CMO)?
Drug Product is the finished dosage form patients use (tablets, capsules, injectables, sprays, creams, etc.). Drug Product outsourcing typically means working with a Contract Manufacturing Organization (CMO) to manufacture, validate, package, and release finished dosage forms under GMP for your target markets.
A pharmaceutical CMO focuses on manufacturing execution: tech transfer, GMP production, validation, packaging, and supply continuity. If you still need substantial formulation work or process development, you may need a broader contract development manufacturing organization scope. This directory is optimized for buyers who are comparing CMO services and contract manufacturing services by real-world fit.
- Choose a CMO when your process is defined and you need manufacturing capacity, validation, packaging, and predictable supply.
- Prioritize dosage form fit (sterile vs non-sterile, device needs, line compatibility, packaging components).
- Verify regulatory readiness for your markets: FDA/EMA experience, documentation, change control, and release workflow.
- Use this pharmaceutical CMO directory to shortlist and request quotes from the right providers faster.
Drug Product buyer guide (CMO)
Use this quick guide to evaluate CMO services and avoid common delays in tech transfer, validation, and packaging.
How to choose the right Contract Manufacturing Organization
- Dosage form fit: match the exact formats you need (sterile vs non-sterile, device needs, packaging lines).
- Tech transfer ownership: confirm who owns documents, training, and change control.
- Validation strategy: align to stage and markets (clinical vs commercial).
- Packaging reality: line compatibility and component lead times are frequent blockers.
- Regulatory compliant CMO: confirm inspections/certifications relevant to your target markets.
What to include in your first message (RFQ)
- Dosage form: tablets/capsules, liquids, semi-solids, sterile injectables, inhalation, etc.
- Fill-finish format: vials, prefilled syringes, ampoules, lyophilized powders, pens.
- Stage + markets: investigational vs commercial; FDA/EMA/others.
- Volumes: batch size and annual demand estimate.
- Constraints: cold chain, device/combination requirements, special packaging.
- Timeline: desired start date, first batch, launch window.
Common pitfalls in Drug Product outsourcing
- Capacity surprises: the facility can do it, but not in your timeframe.
- Packaging constraints: components and line compatibility often take longer than expected.
- Validation gaps: misaligned validation scope causes delays and rework.
- Scope confusion: if development is still needed, pure CMO execution may not be enough.
Drug Product CMO services FAQ
Practical answers buyers look for when hiring a CMO and comparing contract manufacturing companies.
What is a Contract Manufacturing Organization (CMO)?
A CMO is a contract partner focused on manufacturing execution under GMP. For drug products this often includes tech transfer, validation, routine manufacturing, packaging, and supply continuity.
What does “CMO services” usually include?
Typical CMO services include tech transfer, GMP manufacturing, validation support, packaging, QC testing where applicable, and batch release workflows aligned to target markets.
When should I choose a CMO instead of a CDMO?
Choose a CMO when the formulation and process are largely established and you need manufacturing capacity and reliable supply. Choose CDMO scope when you still need development work (formulation/process development/method development).
How do I shortlist pharmaceutical CMO providers fast?
Start with dosage-form fit (sterile vs non-sterile, device needs), then filter by certifications and target markets (FDA/EMA), capacity, and realistic timelines. This directory is built for that workflow.
What should I include in an initial inquiry to a CMO?
Include dosage form, stage, batch sizes and annual demand estimate, target markets, packaging format, cold chain needs, and key quality expectations. Clear inputs lead to faster, more accurate proposals.
What is fill-finish and why does it matter?
Fill-finish is the step where drug product is filled into final containers (vials, syringes, pens) and packaged. Facility design, sterility assurance, and packaging components often drive timelines and feasibility.
How do I evaluate a regulatory compliant CMO?
Confirm market experience (FDA/EMA), inspectable quality systems (deviations/CAPA, change control), documentation readiness, and whether the specific facility/suites are in-scope for your product type.
What affects lead times the most in drug product contract manufacturing?
Capacity windows, packaging component lead times, validation strategy, and analytical/QC readiness are common drivers. Sterile injectables and complex packaging formats typically require longer planning.
Do contract manufacturers handle packaging too?
Many do, but packaging capability is not universal. Validate line compatibility, serialization requirements, component sourcing responsibilities, and release workflows.
What are “custom CMO services” and when do I need them?
Custom CMO services usually mean tailored packaging, special handling (cold chain), device requirements, or non-standard batch strategies. Use them when your product needs go beyond a standard manufacturing run.
How do I compare contract manufacturing companies fairly?
Compare on dosage-form fit, proven experience, certifications and market history, QA maturity, realistic lead times, and packaging capabilities. Use filters first, then deep-dive with RFQs.
Is an NDA required before contacting a CMO?
Often not for a high-level brief. Most buyers share a concise scope first and sign an NDA when detailed transfer documents are needed.
Why use a pharmaceutical CMO directory instead of searching manually?
Manual search is slow and inconsistent. A directory approach lets you compare providers by the same criteria (dosage form, certifications, markets, scale), so you can shortlist faster and avoid contacting mismatched suppliers.
What is the difference between contract manufacturing services and CDMO services?
Contract manufacturing services usually focus on execution and supply. CDMO services typically include development work alongside manufacturing. For drug product, choose based on whether you need development or mainly manufacturing capacity.
Can I send one request to multiple CMOs?
Yes. If you’re unsure, use the open inquiry option: one message with your requirements routed to relevant CMOs, helping you compare responses without repeating the same work.
What are pharma contract fillers?
“Pharma contract fillers” usually refers to CMOs that perform fill-finish operations, especially for sterile injectables. Verify container formats, aseptic capabilities, and packaging lines for your product.
Oral solid products
Oral solid outsourcing means working with a Contract Manufacturing Organization to manufacture tablets, capsules,
granules, or powders as finished dosage forms. Typical steps include blending, granulation, compression or encapsulation, coating,
in-process controls, and packaging into bottles, blisters, or stick packs.
Key constraints include content uniformity, moisture sensitivity, tooling availability, and dissolution performance. A strong oral solid CMO
also manages packaging component lead times and serialization needs for your target markets.
Use this guide to evaluate oral solid contract manufacturing services and avoid delays during tech transfer and scale-up.
Short answers to common questions about oral solid dosage form outsourcing and tablet manufacturing CMOs.
An oral solid products CMO manufactures tablets, capsules, powders, and granules as finished dosage forms. Services often include blending, granulation, compression, coating, encapsulation, and packaging. Yes. Tablet manufacturing focuses on compression tooling, hardness, friability, and coating, while capsule filling centers on fill weights and shell compatibility. A qualified CMO can offer both and advise on equipment fit. Many CMOs provide wet and dry granulation services to improve flow and content uniformity. Ask about equipment scale, binder systems, and moisture control for your formulation. Common formats include blisters, bottles, stick packs, and sachets. Packaging line compatibility and component lead times are frequent decision factors. Key tests include assay, content uniformity, dissolution, hardness, and stability. Your CMO should align methods and specifications to target markets. Some do. For high-potency APIs, confirm containment, occupational exposure limits, and cleaning validation strategies. Batch size depends on scale-up, market demand, and equipment capacity. Share your clinical or commercial forecast to confirm line fit early. It includes documentation review, trial blends or engineering batches, process validation, and stability initiation. Timelines vary with tooling and packaging readiness. Many CMOs offer packaging, but capabilities vary by line and format. Confirm serialization, labeling, and artwork management support. Common issues include blend segregation, compression scale-up surprises, and coating defects. Early process characterization and realistic timelines help reduce risk. Compare equipment capabilities, regulatory history, capacity windows, and packaging flexibility. Use this directory to shortlist CMOs by oral solid fit. Oral solid outsourcing is a subset of finished dosage form manufacturing focused on tablets and capsules. A drug product CMO can also support other dosage forms if needed. Many CMOs support stability storage and release testing, sometimes via in-house or partner labs. Clarify scope and data ownership in your RFQ. Provide formulation details, target dose, granulation method, tooling requirements, batch sizes, packaging format, and target markets. Clear inputs reduce RFQ back-and-forth.What is oral solid products outsourcing (CMO)?
When to choose a CMO for oral solid products
Common buyer requirements
Drug Product buyer guide (CMO)
How to choose the right Contract Manufacturing Organization for oral solids
RFQ template: what to include for oral solid products
Common pitfalls in oral solid contract manufacturing
Validation and regulatory notes for oral solid products
Oral Solid Products CMO services FAQ
What does an oral solid products CMO manufacture?
Is tablet manufacturing CMO support different from capsule filling?
Can a CMO help with granulation services for oral solids?
What packaging formats are common for oral solid drug product manufacturing?
Which quality tests matter most for oral solid dosage forms?
Do oral solid CMOs handle high-potency compounds?
How should I size batches for oral solid contract manufacturing?
What is the typical tech transfer workflow for oral solid products?
Do oral solid CMOs provide pharmaceutical packaging services?
What are common pitfalls in oral solid contract manufacturing?
How do I compare pharmaceutical contract manufacturing organizations for tablets?
Is finished dosage form manufacturing the same as oral solid outsourcing?
Can a pharma CMO services team support stability and release testing?
What documentation should I provide for a tablet manufacturing RFQ?
Sterile injectables
Sterile injectables outsourcing is working with a Contract Manufacturing Organization to aseptically fill and finish
injectable drug products, including vials, syringes, ampoules, and cartridges. Typical steps include compounding, sterile filtration,
filling, stoppering, inspection, and secondary packaging.
Key constraints include sterility assurance, container closure integrity, endotoxin control, and cold chain requirements. Sterile injectable
CMOs also manage component sourcing and line changeover planning.
Use this guide to compare sterile injectable contract manufacturing services and avoid delays in aseptic processing.
Practical answers for buyers searching for sterile fill finish CMOs and injectable drug product manufacturing.
Sterile injectables CMOs manufacture vials, prefilled syringes, ampoules, and cartridges. Services include aseptic fill finish, terminal sterilization, and packaging. Sterile fill finish involves filling drug product into sterile containers under aseptic conditions, followed by stoppering, capping, inspection, and packaging. Many do. Confirm lyophilizer size, cycle development support, and vial handling equipment if your product requires freeze-drying. Common formats include vials, prefilled syringes, ampoules, and pens. Each format has specific component and inspection requirements. Review cleanroom classification, environmental monitoring, media fill history, and operator training. These indicators show sterility assurance performance. Some CMOs handle biologic drug products with cold chain or low-temperature filling. Confirm material compatibility and temperature controls. Batch sizes range from small clinical lots to large commercial runs. Provide your forecast to match line speed and vial size capabilities. Aseptic fill finish maintains sterility throughout processing, while terminal sterilization sterilizes the sealed container after filling. Product sensitivity often determines the approach. Many CMOs provide secondary packaging, labeling, and serialization. Confirm compatibility with your device or combination product needs. Common pitfalls include component shortages, media fill delays, and container closure integrity issues. Early planning helps align timelines. Compare sterility assurance history, container format capabilities, inspection systems, and regulatory track record. Use this directory to shortlist sterile fill finish CMOs. Some CMOs provide cold chain handling and refrigerated storage, but not all. Clarify temperature ranges and monitoring expectations in your RFQ. Include container format, fill volume, sterility approach, batch size, and packaging requirements. Provide stability data and target markets for regulatory alignment. Yes. Visual inspection and container closure integrity testing are common parts of injectable drug product manufacturing.What is sterile injectables outsourcing (CMO)?
When to choose a CMO for sterile injectables
Common buyer requirements
Drug Product buyer guide (CMO)
How to choose the right Contract Manufacturing Organization for sterile injectables
RFQ template: what to include for sterile injectables
Common pitfalls in sterile injectables outsourcing
Validation and regulatory notes for sterile injectables
Sterile Injectables CMO services FAQ
What does a sterile injectables CMO manufacture?
What is sterile fill finish CMO support?
Do sterile injectable CMOs offer lyophilization?
What are common container formats for injectable drug product manufacturing?
How do I evaluate aseptic processing capabilities?
Can CMOs handle biologics in sterile injectable formats?
What batch sizes are typical for sterile injectable CMOs?
What is the difference between aseptic fill finish and terminal sterilization?
Do sterile injectable CMOs provide pharmaceutical packaging services?
What are common pitfalls in sterile injectables outsourcing?
How do I compare pharmaceutical contract manufacturing organizations for sterile injectables?
Is cold chain support common for injectable CMOs?
What should I include in a sterile injectable RFQ?
Does finished dosage form manufacturing include injectable inspection?
Tablets & Capsules
Tablets and capsules are common oral solid forms. CMOs offer formulation, compression, encapsulation, and GMP-compliant manufacturing services.
Liquid Vials
Liquid vials are injectable formats requiring aseptic filling. CMOs offer vial washing, sterilization, filling, and sealing services.
Prefilled Syringes
Prefilled syringes enhance ease of use and reduce contamination risk. CMOs provide sterile filling, plunger insertion, and labeling services.